Iht Wealth Management, LLC Crispr Therapeutics Ag Transaction History

Iht Wealth Management, LLC

$3.44 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $68,772 - $91,633	-1,344 Reduced 19.74%	5,464 $295,000
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $6,673 - $9,803	-110 Reduced 1.59%	6,808 $464,000
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $25,180 - $47,061	-652 Reduced 8.61%	6,918 $433,000
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $18,156 - $23,600	-400 Reduced 5.02%	7,570 $343,000
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $9,172 - $14,299	-211 Reduced 2.58%	7,970 $447,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $78,679 - $107,694	-1,919 Reduced 19.0%	8,181 $370,000
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $2,155 - $3,611	55 Added 0.55%	10,100 $410,000
Q3 2022 Nov 22, 2022	BUY	$61.1 - $83.78 $163,014 - $223,525	2,668 Added 36.17%	10,045 $656,000
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $345 - $590	-8 Reduced 0.11%	7,377 $448,000
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $58,525 - $92,927	835 Added 12.75%	7,385 $560,000
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $303,050 - $430,759	-2,750 Reduced 29.57%	6,550 $733,000
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $70,588 - $113,322	700 Added 8.14%	9,300 $1.51 Million
Q1 2021 May 18, 2021	SELL	$110.72 - $210.04 $90,347 - $171,392	-816 Reduced 8.67%	8,600 $1.05 Million
Q4 2020 Feb 17, 2021	BUY	$79.67 - $173.23 $128,189 - $278,727	1,609 Added 20.61%	9,416 $1.44 Million
Q3 2020 Nov 19, 2020	BUY	$78.5 - $100.64 $269,098 - $344,993	3,428 Added 78.28%	7,807 $653,000
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $168,591 - $333,022	4,379 New	4,379 $322,000
Q3 2019 Nov 15, 2019	SELL	$40.99 - $52.56 $220,649 - $282,930	-5,383 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$35.45 - $48.2 $190,827 - $259,460	5,383 New	5,383 $254,000
Q4 2018 Feb 15, 2019	SELL	$22.73 - $42.34 $114,809 - $213,859	-5,051 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$42.62 - $73.59 $21,310 - $36,795	-500 Reduced 9.01%	5,051 $297,000
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $1,176 - $2,908	50 Added 0.91%	5,551 $240,000
Q3 2017 Nov 14, 2017	BUY	$16.75 - $20.66 $92,141 - $113,650	5,501	5,501 $108,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$367 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$347 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$139 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$137 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$137 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.

Account